26 closest matches · ranked by relevance
Relapsing-Remitting Multiple Sclerosis (RRMS)
Primary: Change From Baseline in Convenience Satisfaction Score of Treatment Satisfaction Questionnaire to Medication (TSQM-9) at Week 12 — 38.5; 38.5 score on a scale — p=0.56
Myopia
Primary: Subject Satisfaction — 50 Participants
Glabellar Frown Lines
Primary: Subject Satisfaction When Treated With abobutulinumtoxinA in Their Glabellar Lines — 66; 38; 4; 2 Participants
Pulmonary Disease, Chronic Obstructive
Primary: The Patients' Satisfaction With Chronic Obstructive Pulmonary Disease (COPD) Medical Treatments During a 12-month Observation Period — 64.2; 66.2; 67.1; 75.8 Unit on Scale
Rheumatoid Arthritis
Primary: Treatment Satisfaction Questionnaire for Medication (TSQM) Version 1.4 — 62.271; 64.191; 93.390; 96.603 units on a scale — p=0.3648
Critical Illness
Primary: Family Satisfaction in the ICU (FS-ICU) Questionnaire- Overall Satisfaction Score — 78.3 units on a scale
Psoriasis
Primary: Participant Satisfaction With Injection Device Evaluated at Week 12 for Modified Intent-to-treat (mITT) Population — 8.9; 7.6 units on a scale — p=<0.001
Satisfaction · Trauma
Primary: Patient Satisfaction as Measured by Giving an "Excellent" Score on a 5-point Rating — 25; 22 participants
Outcome Assessment · Patient Satisfaction
Primary: Overall Patient Satisfaction — 247; 53 Participants
Patient Satisfaction
Primary: Patient Satisfaction With Pain Control in Labor — 5; 5 score on a scale — p=0.16
Satisfaction
Primary: Anxiety — 2.9; 1.4 NRS
Glabellar Frown Lines
Primary: Percentage of Participants With Improvement in Subject Global Assessment of Change at Day 30 — 94.7; 0.00 Percentage of participants
Impotence
Primary: Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index at the End of the DB Treatment (Week 8) — 80.27; 62.15 scores on a scale — p=<0.0001
Lip Augmentation
Primary: Assess Treatment With Restylane Kysse Using GAIS — 18; 38 Participants
Cheek Augmentation
Primary: Assess Treatment With Restylane Volyme and Restylane Lyft Lidocaine Using GAIS — 20; 17; 9; 9 Participants
Patient Satisfaction
Primary: Patient Satisfaction — 120; 116 units on a scale
Facial Rhytides · Skin Folds · Loss of Volume and Skin Quality
Primary: Change From Baseline in the Rasch-transformed Score of the FACE-Q Satisfaction With Facial Appearance Scale. — 46.6 units on a scale — p=<0.0001
Skin Aging
Primary: The First Visit Onset of Efficacy as Measured by Physician Assessment — 2.2 Number of Days
Migraine
Primary: Mean Change From Baseline in the Treatment Satisfaction Questionnaire for Medication (TSQM) Overall Satisfaction Scale Score at Week 24 by SoC — 42.33; 34.42 Score on a…
Colon Cancer · IBS · Polyps
Primary: Patient Satisfaction — 259; 222; 37; 66 Participants
Astigmatism
Primary: Satisfaction With Comfort of T30fA Lens — 8 score on a scale
Seborrheic Keratosis
Primary: Subject Satisfaction — 21; 14; 4; 0 Participants
Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality
Primary: Change From Baseline in Rasch-transformed Score of FACE-Q Satisfaction With Facial Appearance Overall Scale to End of Study — 40.9; 37.8; 21.5; 32.9 score on a scale…
Hepatitis C, Chronic · Hepacivirus
Primary: Number of Participants Satisfied With the PegIntron Pen, Including the Assessment of the Device Accuracy and Ease of Use. — 104; 102; 102; 102 Satisfied Participants
Aging
Primary: Subject Satisfaction for the Full Face — 92.9; 7.1 percentage of total subjects
Allergic Rhinitis
Primary: Overall Best-Worst Scaling Task Index Score (Treatment Satisfaction Index Score) — 68.26; 62.78 units on a scale — p=<.001